Back to search

Article

Co-opting regulation bypass repair (CRBR) as a gene correction strategy for monogenic diseases

2020-12-19

Abstract excerpt

With the development of CRISPR/Cas9-mediated gene editing technologies, correction of disease- causing mutations has become possible. However, current gene correction strategies preclude mutation repair in post-mitotic cells of human tissues, and a unique repair strategy must be designed and tested for each and every mutation that may occur in a gene. We have developed a novel gene correction strategy, Co-opting R...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
8e9f1043-19a3-58e7-b57d-4738be5696db
DOI
10.1101/2020.12.17.423314
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Co-opting regulation bypass repair (CRBR) as a gene correction strategy for monogenic diseasesDOI 10.1101/2020.12.17.423314
Select a neighboring publication to make it the new centre.